Skip to main content

Peptide Profile

FGL

FGL peptide · NCAM FGL · neural cell adhesion molecule-derived peptide

FGL (EVYVVAENQQGKSKA) is a synthetic 15-amino-acid peptide derived from the fibronectin type III homology domain 2 of the neural cell adhesion molecule (NCAM), designed as a pharmacomimetic agonist of NCAM to activate…

Neuro & CognitiveNot EvaluatedResearch Only
Routes
subcutaneous

Educational research information — not medical advice. Review primary sources and consult a qualified professional before any decision.

Educational research tools — not medical advice.

Overview

What FGL is

About FGL

Mimics NCAM-mediated signaling via FGFR (fibroblast growth factor receptor) activation. Stimulates downstream Erk1/2 and PLCγ pathways. Promotes long-term potentiation (LTP) and synaptogenesis.

FGL (EVYVVAENQQGKSKA) is a synthetic 15-amino-acid peptide derived from the fibronectin type III homology domain 2 of the neural cell adhesion molecule (NCAM), designed as a pharmacomimetic agonist of NCAM to activate FGFR-mediated neurotrophic signaling and mimic the synaptogenic and neuroprotective effects of NCAM receptor engagement in the central nervous system. FGL activates downstream FGFR signaling to promote synaptic plasticity, neuronal survival, and spatial learning in preclinical models; rodent studies have demonstrated cognitive-enhancing and anxiolytic effects in aged animals and in models of neurodegeneration, establishing a preclinical rationale for further investigation. No published human clinical trials, pharmacokinetic studies, or safety evaluations of FGL have been indexed in PubMed; the entirety of the evidence base consists of animal and in vitro studies, and no regulatory body has approved or evaluated FGL for any human indication. FGL has no FDA approval or regulatory approval in any jurisdiction; it is a research compound with a defined neurotrophic mechanism and an exclusively preclinical evidence base, and no clinical data exists to inform its pharmacokinetics, safety, or therapeutic utility in humans.

FGL Benefits & Research Areas

synaptic plasticitymemory enhancementneuroprotectionLTP promotion
The Research

What the evidence says about FGL

Regulatory Status

Availability Status
Research Only
FDA Status
Not Evaluated

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

FGL Side Effects & Safety Considerations

Research-use compound with limited human data. Evidence strength varies — see the Evidence section.

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Frequently Asked Questions — FGL

FGL (EVYVVAENQQGKSKA) is a synthetic 15-amino-acid peptide derived from the fibronectin type III homology domain 2 of the neural cell adhesion molecule (NCAM), designed as a pharmacomimetic agonist of NCAM to activate FGFR-mediated neurotrophic signaling and mimic the synaptogenic and neuroprotective effects of NCAM receptor engagement in the central nervous system. FGL activates downstream FGFR signaling to promote synaptic plasticity, neuronal survival, and spatial learning in preclinical models; rodent studies have demonstrated cognitive-enhancing and anxiolytic effects in aged animals and in models of neurodegeneration, establishing a preclinical rationale for further investigation.

synaptic plasticity, memory enhancement, neuroprotection, LTP promotion.

Research on FGL primarily documents effects related to synaptic plasticity and memory enhancement and neuroprotection and LTP promotion. These are areas covered in preclinical and clinical literature — individual response varies and effects depend on context of use.

For FGL, its FDA status is not evaluated by the FDA, and it is designated for research use only. Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

2 providers in the directory currently offer FGL.

Access

How to get FGL

Where to buy FGL

2 providers
2 in stock

Questions to ask your provider

Stay updated on verified FGL providers

New verified providers added weekly — delivered to your inbox.

Weekly research digest. No spam. Unsubscribe anytime.

Last updated

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.